Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Aug 07 2024

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-aug-07-2024-15

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 07, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Acitretin Capsules USP, 10 mg, 17.5 mg, and 25 mg.".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

In the deck

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases